ÖZET
Polymorphonuclear granulocytes use proteinases to digest these agents and tissue debris. One of these proteinases is PMN elastase, which is localized in the azurophilic granules of the polymorphonuclear granulocytes (14) (15) (16) (17) . Elastase is considered to be one of the most potent proteolytic enzymes present in azurophilic granules of neutrophils. It plays an important physiological function in degrading phagocytosed substances and facilitating cell migration through vascular walls. Excessive amounts of free elastase, unbound to natural inhibitors present in systemic fluids, may result in the enzyme becoming hazardous for the surrounding tissues. Elastase degrades mainly the essential elements of the interstitium (elastin, collagen, proteoglycans), but it also, as a non specific enzyme, causes decomposition of plasma transport proteins, proteinase inhibitors, blood coagulation factors, immunoglobulins and the basal membrane of renal glomeruli. A particular role is played by elastase in the pathogenesis of chronic respiratory diseases, as it damages the ciliary epithelium and enhances mucus production (13) (14) (15) (16) (17) (18) .
The aim of the study was determine the sensitivity and specificity of PMN elastase levels for the diagnosis of neonatal sepsis and investigate its role in determining the efficacy of treatment and the prognosis of the disease.
Material and Methods
This prospective study was performed on newborns who were hospitalized for neonatal sepsis at the Neonatal Intensive Care Unit, Pediatric Department, Haseki Training and Research Hospital, Istanbul, Turkey. The protocol was approved by the local ethics committee. Informed written consent was obtained from parents of all the patients.
Forty newborns were diagnosed as suspected clinical sepsis based on their Hematological Score and Töllner Score (19) results (Hematological Score ≥3 and Töllner Score ≥10). Clinical signs of sepsis were defined as the presence of three or more of the following categories of clinical signs: apnea, tachypnea (>60/min), respiratory distress, hypotonia, bradycardia (<100/min), tachycardia (>180/ min), seizures, change in skin colour and perfusion, irritability, and lethargy. Two or more abnormal values of the sepsis screen were considered as supportive for diagnosis of infection. The control group included twenty neonates who were admitted to the hospital with non-infectious diseases, such as hypoglycemia, indirect hyperbiluribinemia, intrauterine growth retardation, transient tachypnea, without clinical findings of infection.
Before starting antibiotic therapy, blood samples for blood culture, routine biochemistry, whole blood count, peripheral blood smear, immature neutrophil: total neutrophil (I/T) ratio, C-reactive protein (CRP) and PMN elastase were taken. Chest radiograph, cerebrospinal fluid culture and urine culture were done whenever clinically indicated. Antibiotics were commenced after the blood specimens were collected. Second blood samples for sepsis markers were obtained from these patients on the 4th day of treatment.
Complete blood counts were carried out with an automatic counter. Leukocytosis was considered if the white blood cell (WBC) count was more than 25000/mm 3 and leukopenia less than 5000/ mm 3 , and thrombocytopenia less than 100000/mm 3 . By examining peripheral blood smears prepared with Giemsa stain, band forms, myelocytes and metamyelocytes in leukocyte formula evaluated as immature neutrophils and I/T ratio were calculated. Pathologic I/T ratios were greater than 0.2. Specimens of blood were obtained from each infant by a sterile technique and were inoculated into commercially-prepared BD Bactec Peds Aerobic/F vials (Peti-Bact blood culture, Organon Technica). Positive cultures were detected by chemical sensors sensitive to increases in carbon dioxide produced by growth of the organisms. The organisms were then identified based on gram staining and growth on agar media.
Blood samples were obtained on the 1 st and 4 th days, their serum extracted and CRP investigation was made immediately, remaining serum was preserved for PMN elastase evaluation. Blood samples that were obtained from the control group and from neonates with sepsis were centrifuged at 2500 x g for 15 min and the serum portion was preserved by freezing at -20°C for PMN elastase studies.
C-reactive protein level was measured by the Behring Nephelometer 100 Analyzer BN II (NY, USA). CRP levels ≤6 mg/L were accepted as normal. Blood analyses were carried out in the bacteriology and biochemistry laboratories of Haseki Training and Research Hospital (Istanbul, Turkey).
Polymorphonuclear elastase levels were measured with an enzymelinked immunosorbent assay (ELISA) with PMN elastase study kits (BMS 269-Austria). The samples were studied in the hematology laboratory of Türkiye Yüksek İhtisas Education and Research Hospital (Ankara, Turkey).
Statistical analysis
The Statistical Package for Social Sciences for Windows version 11.0 (Sigma Stat; SAS Institute Inc.) was used for statistical analysis. The results were given as mean±standard deviation. Comparisons between the two groups were analyzed by the unpaired Student's ttest for normally distributed (parametric) data and Mann-Whitney U test for non-parametric data. P value less than 0.05 was considered to be statistically significant. To determine a diagnostic value for PMN elastase and CRP in newborns, a ROC curve was constructed for each sampling point. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated at different selected cut-off values for each marker and for combinations of markers. The Wilcoxon test was used for the interpretation of the difference between at time of diagnosis and after therapy.
Results
In this study, 40 neonates with sepsis (Sepsis Group) and 20 healthy neonates (Control Group) were investigated. Characteristics of the participants are shown in Table 1 and Table 2 . There were no significant differences in gender and birth place between the two groups (chi square test; p>0.05). In addition, there were no significant differences between the groups with respect to mean gestational age, age and birth weight (Student's t-test; p>0.05). The age of onset of sepsis ranged from day 2 to day 30. Except for one infant, all others presented at more than 72 hours of age. Therefore, ü the distinction of early and late sepsis has not been made.
Fourteen patients had positive blood culture in the neonatal sepsis group. Staphylococcus epidermidis (n=5, 12.5%), Klebsiella oxitoca (n=4, 10%), Klebsiella pneumoniae (n=2, 5%), Staphylococcus hemolyticus (n=2, 5%), Group B streptococcus (n=1, 2.5%) were isolated from blood culture (Table 3) . Two patients had meningitis; no pathogen was isolated from the cerebrospinal fluid (CSF), however, Klebsiella oxitoca and, the other coagulase-negative Staphylococci were present in their blood samples (Table 3 ). There was no significant difference in PMN elastase or CRP levels between proven sepsis and culture-negative sepsis (Student's t-test; p>0.05) ( Table 4) .
Polymorphonuclear elastase levels, CRP levels, I/T ratio, white blood cell count and platelet count in the Sepsis and Control Groups are shown in Table 5 . We found that mean serum PMN elastase levels, CRP levels and I/T ratio were significantly higher in the Sepsis Group than those in the Control Group (Student's t-test; p<0.001). No significant difference was found in WBC count or platelet count between the groups (Student's t-test; p>0.05).
The specificity, sensitivity, negative predictive value (NPV) and positive predictive value (PPV) were identified using ROC analysis for the first day. As shown from Table 6 , the highest specificity (96.3%), sensivity (90.3), NPV (93.5) and PPV (95.1%) were found for PMN elastase levels in prediction of sepsis. The sensitivity of CRP in detecting sepsis was 90.3%, its specificity was 91.2%, its positive predictive value was 89.7% and its negative predictive value was 89.7%. IT ratio had a high specificity and PPV, but lower sensitivity and NPV. In determining sepsis, platelet count was found to be the lowest sensivity and NPV.
Serum values of CRP and PMN elastase before treatment and at the 4 th day of treatment are shown in Table 7 . Before treatment, serum PMN elastase and CRP levels were significantly higher than levels at the fourth day of antibiotic treatment, showing a significant recovery with antibiotic in the Sepsis Group
In 7 patients having normal CRP levels of the Sepsis Group (<5 mg/dL), PMN elastase levels were higher than the control group (157.42±23.78, t=17.51, p=0.000). In the control group, none of PMN elastase levels was high, while ten newborns had raised CRP levels (≥5 mg/dL).
Discussion
In this study, 40 septic neonates and 20 healthy neonates were investigated to evaluate the value of serum PMN elastase and CRP in determining early diagnosis and prognosis of neonatal sepsis. It was established that mean serum PMN elastase and CRP values before treatment were significantly higher in septic neonates compared with healthyones, and PMN elastase had high sensitivity and specificity in the early diagnosis of neonatal sepsis. PMN elastase detection was particularly valuable in determining early diagnosis and the prognosis of the disease.
Neonatal sepsis is still a leading cause of mortality in neonatal intensive care units all over the world. Early diagnosis and treatment of the newborn infant with suspected sepsis are essential to prevent severe and life threatening complications (3). Since the symptoms and findings are nonspecific, neonatal sepsis diagnosis is quite difficult. There is a great need for new diagnostic laboratory methods for the early diagnosis of the disease and the evaluation of prognosis and treatment efficacy.
Clinical manifestations are nonspecific and laboratory parameters such as WBC count or I/T ratio are of limited value in identifying infected newborns (20) . Blood culture is the gold standard laboratory technique for the diagnosis of infection, but culture results may (21) . False negative culture may also occur (3). As a consequence, appropriate diagnosis and therapy could be delayed, worsening the prognosis of the patient (21).
For years, investigators have searched for a test or panel of tests able to identify septic neonates accurately and rapidly while awaiting culture results, in order to obtain an early diagnosis and develop a specific effective treatment for a successful outcome. When high mortality of neonatal sepsis is taken into consideration, it is desirable for the ideal diagnostic tests with maximal sensitivity and negative predictive value. To minimize the unnecessary use of antibiotics in false-positive cases, a diagnostic marker also needs to have reasonably high specificity and a good PPV (22) .
Hematological parameters have been evaluated in previous studies. WBC count, total neutrophil count, immature neutrophil count, I/T ratios, platelet count are the indices most commonly used. These hematological counts and ratios showed a limited accuracy with wide range of sensitivity (17-90%) and specificity (31-100%), due to the relatively long period necessary to become positive and the significant influence of non-specific factors. However, I/T ratio of >0.2 may reach a sensitivity of 90% and negative predictive value of 98% (22) . In this study, WBC and platelet count showed low detection sensitivity, specifity, NPV and PPV in neonatal infection (p>0.05), and I/T ratio failed to reach an appropriate sensitivity and NPV in neonatal sepsis.
Since the end of the 1980s, CRP has been routinely investigated and used for the diagnosis of neonatal sepsis. CRP is an acute phase protein synthesized by the liver within 6-8 hr in response to inflammatory cytokines, peaks at 24-48 hr, and then diminishes rapidly after elimination of the source (23) . Elevated levels of CRP are present during bacterial, viral and other infections, and in noninfectious inflammatory diseases and malignancies (22) . In variable studies using CRP ≥1 mg/dL as the cut-off value, the range of reported statistical outcomes is as follows: sensitivity 70% to 93%; specificity 41% to 98%; positive predictive accuracy 6% to 83%; and negative predictive accuracy 97% to 99% (23) . On the other hand, quantitative CRP values, particularly when repeated, are highly specific and have good sensitivity. In addition, serial measurements can be helpful in monitoring the response to treatment. In spite of the reduced early sensitivity, CRP still remains the preferred index in most neonatal intensive care units (22) . In this study CRP levels on the first day were significantly higher than control groups (p<0.001). After antibiotic treatment CRP levels were decreased by the fourth day (p<0.01). However, in seven infants, PMN elastase levels were measured high while CRP levels were normal. The increase in the serum levels of CRP is rather slow during the first 12-24 hours of infection, and this may cause false negative results. In addition, increase in CRP levels in non-infected clinical conditions (trauma, surgical intervention, recent vaccination, prolonged rupture of membranes, fetal distress, perinatal asphyxia, intraventricular hemorrhage, meconium aspiration, burns and malignancies) can cause a false positive test. In our study, in the control group PMN elastase levels were normal in all of the cases. On the contrary, ten newborn in the control group also had raised CRP levels. This increase in CRP concentrations in the control group is thought to affect the specificity of the test. Our findings suggest that PMN elastase is more sensitive and specific than CRP.
In the past few decades, acute phase proteins, cytokines, adhesion molecules, chemokines, cell surface markers, complement system components, and combinations of these were investigated for the early and reliable diagnosis of the neonatal sepsis. Results of different published studies in relation to IL-1β and TNF-α are contradictory. Publishing data regarding TNF-α is alsocontradictory. Some studies found the diagnostic utility of this cytokine, while others demonstrated similar or even lower levels in infected newborns compared to healthy newborns (24) (25) (26) (27) .
Polymorphonuclear elastase is a serine protease stored in the azurophilic granules of neutrophils and secreted by neutrophils during inflammation (13, 15, 17) . The exact role PMN elastase in early detection of neonatal sepsis was not well investigated. Investigations, performed mainly in adults, are still rare in pediatric patients. There are numerous studies indicating that neutrophils play an important Various published studies have shown PMN elastase to be a useful marker of early infection in the newborn. Tsaka et al. (28) showed that septic newborns had significantly increased PMN elastase levels at the time of recognition of infection. Jensen et al. (29) and Wojsky et al. (30) found that PMN elastase is higher in septic than in nonseptic newborns. In this study, it was detected that PMN elastase levels of newborns with sepsis were significantly higher than controls (p<0.001). Lawskoska et al. (31) also found that in full-term neonates cord blood neutrophil elastase is a good marker of infection.
Wojsky et al. (30) reported that the sensitivity and a specifity of serum PMN elastase in the early diagnosis of neonatal sepsis were 76%, 81%, respectively. In our study, the sensitivity of PMN elastase in the diagnosis of neonatal sepsis was 91.2%, specificity was 96.3%, PPV was 95.1% and NPV was 93.5%. CRP results for sepsis were 91.2% sensitivity, 90.3% specifity, 89.7% PPV and 91.1% NPV. The results of this study showed that the sensitivity, specifity, PPV and NPV of the PMN elastase were high for early diagnosis of neonatal sepsis. Our findings suggest that PMN elastase is an almost perfect marker and more sensitive and specific than CRP in the diagnosis of neonatal sepsis. However, lack of correction for reference ranges for neonatal PMN elastase values may influence the outcome of PMN elastase as a marker for bacterial infection. In addition, methodological difficulties in detecting PMN elastase and the absence of their routine usage in all centers have limited its use in daily practice.
Another characteristic of the markers that are used in the diagnosis of neonatal sepsis is that it gives information about the prognosis of the disease and helps in coming to a decision as to whether to stop or continue antibiotic treatment. In this study, it is found that PMN elastase levels were statistically decreased in newborns after 4 th day of therapy compared to newborns at the time of diagnosis (p<0.001). Similar results have been obtained by Tsaka et al. (28) . When blood samples obtained before treatment and on the 4 th day of treatment both from patients recovered and from those who died were compared, it was observed that mean serum PMN elastase values were significantly decreased in recovered patients during the treatment. On the other hand, mean serum PMN elastase levels were detected to significantly increase in the deceased patients. With these findings, it is observed that PMN elastase is a useful marker in determining the prognosis of the disease and treatment efficacy.
Conclusion
Delay in commencing antibiotic therapy in an infant with sepsis could result in serious consequences. Over-treatment of neonates with antibiotics based on false positive results will promote the emergence of multi-resistant bacteria in the neonatal intensive care unit. We conclude that PMN elastase is an important marker in the diagnosis of neonatal sepsis, and this marker is also valuable in following the effectiveness of treatment and determining the prognosis of the disease. When used with CRP and clinical signs, it will be a useful tool for helping doctors to decide whether antibiotics should be started or withheld at the onset of symptoms in newborns, while awaiting results of the blood culture. However, it is thought that these findings need to be confirmed by means of future studies examining different categories of infections and larger number of neonates.
